China Biopharma IPOs Skyrocket In 2010 After Freeze Is Lifted
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The number of initial public offerings by pharmaceutical and biotech companies in China continued to rise in 2010, continuing a surge in IPOs that started in mid-2009